Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Vendor says RxCompass program could net St. Martin Parish Schools roughly $450,000; weight‑loss drug program would be voluntary with clinical screening
Summary
Lavinity presented RxCompass pathways to the St. Martin Parish Schools board, saying patient‑assistance and international‑mail sourcing could generate roughly $585,000 gross savings on identified prescriptions and about $450,000 net after fees; the vendor said the GLP‑1 weight‑loss program would be voluntary and tied to behavioral‑health participation.
Marcy Maloney, an account executive at Lavinity, opened the board presentation by identifying her firm’s role working with St. Martin Parish Schools and introducing Tom Lane, Lavinity’s senior executive, to review proposed pharmacy and wellness programs. "I'm the account executive here at Lavinity for St. Martin Parish Schools," Maloney said at the start of the presentation.
Lane framed two primary savings pathways the vendor proposed for the district’s benefits plan: a patient‑assistance route that helps members apply for manufacturer programs that can provide medicines at no cost and an international mail option that sources drugs from lower‑cost Canadian pharmacies. "That represents about $450,000 in savings," Lane said when summarizing the program math, adding that the vendor identified 27 unique members and 106 prescriptions tied to the most expensive drugs on the plan.
According to Lane’s presentation, the 106 prescriptions could produce about $585,000 in…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
